Safety, Tolerability and Efficacy of A6 in Patients With Chronic Lymphocytic Leukemia (CLL)
Clinical trial NCT02046928 · TERMINATED
Trial details
- NCT number
- NCT02046928
- Sponsor
- Ångstrom Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2015-11-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.